Literature DB >> 27296168

Association of Selected Adipocytokines and Inflammatory Markers on Body Mass Index in Type 2 Diabetes Patients in Saudi Arabia and as Risk Factors to Cardiovascular Disease.

Antony A Anandaraj1, Prabu Mahin Syed Ismail2, Sultan Mohammed Namis3, Youssef Jadallah Bajnaid4, Sapna B Shetty5, Khalid M Almutairi6.   

Abstract

INTRODUCTION: In this prospective study, we establishing the association of obesity in type 2 diabetes patients with various inflammatory markers and adipocytokines, as risk factors for cardiovascular disease (CVD).
MATERIALS AND METHODS: In this work, a total of 85 individuals gave concern and were divided into 4 groups based on their body mass indices (BMI). Anthropometrics details were obtained from each individual and different laboratory tests were performed to measure levels of adipocytokines such as adiponectin, leptin and resistin and inflammatory markers such as TNF-α, IL-6 and hsCRP. All the 82 patients with T2D were studied in four groups, A includes obese with BMI >30 kg/m2, B includes overweight with BMI ranging 25 to 30 kg/m2), C includes non-obese with BMI < 25 kg/m2. Group D was control, included non-obese (BMI < 25 kg/m2) and non-diabetic individuals. Result &amp; Discussion: There was an increase in plasma insulin levels in T2D patients, especially with exhibiting high BMI and diabetic conditions in Group A. Adiponectin was higher in the control group which is significant with the value of p<0.05 compared to other three groups. There was negative correlation observed found to be significant, between obesity and adiponectin. Positive correlation was seen among leptin, resistin and inflammatory markers among T2D and control individuals which were significant. T2D groups had an increase in plasma insulin and adiponectin, but decreased leptin, resistin and inflammatory markers compared to control. Overall, T2D patients showed a significant correlation between plasma insulin, adipocytokines and other inflammatory markers clearly designate the impact of metabolic conditions such as obesity on these factors and vice versa. Increased levels of the parameters restrained in the study correlate T2D and obesity to cardiovascular diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Adipocytokines; inflammatory markers; obesity; type 2 diabetes

Mesh:

Substances:

Year:  2017        PMID: 27296168     DOI: 10.2174/1573399812666160614014254

Source DB:  PubMed          Journal:  Curr Diabetes Rev        ISSN: 1573-3998


  5 in total

1.  Correlation of serum adipocytokine levels with glycolipid metabolism and inflammatory factors in obese patients with periodontal disease.

Authors:  Zejian Li; Chunting Lu; Jiayu Qiu; Shengwen Liu; Xiaoqi Liu; Shuyuan Ma; Renfa Lai
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 2.  An Overview of the Role of Adipokines in Cardiometabolic Diseases.

Authors:  Tahereh Farkhondeh; Silvia Llorens; Ali Mohammad Pourbagher-Shahri; Milad Ashrafizadeh; Marjan Talebi; Mehdi Shakibaei; Saeed Samarghandian
Journal:  Molecules       Date:  2020-11-09       Impact factor: 4.411

3.  Impact of Obesity-Induced Inflammation on Cardiovascular Diseases (CVD).

Authors:  Gopi Battineni; Getu Gamo Sagaro; Nalini Chintalapudi; Francesco Amenta; Daniele Tomassoni; Seyed Khosrow Tayebati
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

Review 4.  Novel insights into the pathological mechanisms of metabolic related dyslipidemia.

Authors:  Xin Su; Ye Cheng; Guoming Zhang; Bin Wang
Journal:  Mol Biol Rep       Date:  2021-07-04       Impact factor: 2.316

5.  Women with a predisposition for diabetes have an increased risk of pregnancy complications, especially in combination with pregestational overweight.

Authors:  Ulrika Moll; Håkan Olsson; Mona Landin-Olsson
Journal:  BMC Pregnancy Childbirth       Date:  2020-02-03       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.